Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by AKAMPION

< Previous 1 2 3 Next >
News headline image
1ST Biotherapeutics and SK Biopharmaceuticals Announce Exclusive Global License Agreement for Parkinson's Disease Candidate ‘1ST-104’
From AKAMPION
Via GlobeNewswire
News headline image
Omnix Medical Launches New Horizon Europe PEPTAMR Infectious Disease Consortium
From AKAMPION
Via GlobeNewswire
News headline image
TolerogenixX Has Received EMA Orphan Drug Designation for MIC-Lx, Strengthening its Regulatory Pathway in Kidney Transplantation
From AKAMPION
Via GlobeNewswire
News headline image
TolerogenixX Completes Last Patient Transplant in Phase IIb TOL-2 Trial of MIC-Lx, Advancing a New Immune Tolerance Approach in Kidney Transplantation
From AKAMPION
Via GlobeNewswire
News headline image
Omnix Medical Announces First Patients Dosed in Phase II Trial of Antimicrobial Lead Compound OMN6
From AKAMPION
Via GlobeNewswire
News headline image
MetrioPharm AG: Prof. Dr. med. Jürgen Braun Appointed as New Member of the Scientific Advisory Board
From AKAMPION
Via GlobeNewswire
News headline image
Mabylon Reports Positive Phase Ia Results in MY006 Peanut Allergy Trial and Initiates Phase Ib Patient Part of the Study; Advances Tree Pollen Allergy Program MY010 toward Clinical Development
From AKAMPION
Via GlobeNewswire
News headline image
EktaH Shows ~50% Reduction in Post-GLP-1 Weight Rebound with Novel Obesity Treatment and Reports Positive Phase I Data
From AKAMPION
Via GlobeNewswire
News headline image
C-mo Medical Solutions Receives CE Mark for Its Novel AI-Powered Cough Monitoring Solution
From AKAMPION
Via GlobeNewswire
News headline image
Nature Translational Psychiatry Study Reveals Distinct Functional Neuronal Signatures in Patient-Derived Brain Organoids with Itay&Beyond’s Neurotech Platform
From AKAMPION
Via GlobeNewswire
News headline image
EMA Grants PRIME Designation to TolerogenixX’s MIC-Lx Therapy for Donor-Specific Immune Tolerance in Kidney Transplantation
From AKAMPION
Via GlobeNewswire
News headline image
Atopia Therapeutics Reports Preclinical Proof-of-Concept of Lead Compound ATP-R13 in Atopic Dermatitis and Strengthens Patent Protection
From AKAMPION
Via GlobeNewswire
News headline image
Mabylon AG Initiates Phase I Clinical Trial of Lead Compound MY006 for the Treatment of Peanut Allergy
From AKAMPION
Via GlobeNewswire
News headline image
tiakis Biotech Successfully Completes Data Package to Advance Tiprelestat into Phase II clinical trial in PAH
From AKAMPION
Via GlobeNewswire
News headline image
Captain T Cell Closes Financing Round to Advance its Proprietary, Next-Generation TCR-T Pipeline Into the Clinic
From AKAMPION
Via GlobeNewswire
News headline image
selectION Demonstrates Safety and Disease-Modifying Mechanism of Action of its Investigational Drug, si-544, in Phase 1b Proof-of-Concept Trial in Psoriasis, a T Cell-Mediated Autoimmune Disease
From AKAMPION
Via GlobeNewswire
News headline image
ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
From AKAMPION
Via GlobeNewswire
News headline image
Omnix Medical Secures $25 Million in Series C Funding Co-Led by Harel Insurance & Finance and the EIC Fund
From AKAMPION
Via GlobeNewswire
News headline image
Stanford University Secures NIH Grant to Advance tiakis Biotech´s Elafin (Tiprelestat) Through a U.S. Phase II Trial in Pulmonary Arterial Hypertension
From AKAMPION
Via GlobeNewswire
News headline image
BellaSeno Establishes High-Profile Clinical Advisory Board
From AKAMPION
Via GlobeNewswire
News headline image
Mabylon AG Raises CHF 30 Million to Advance Peanut Allergy Lead Program MY006 to Clinical Proof-of-Concept
From AKAMPION
Via GlobeNewswire
News headline image
MetrioPharm’s MP1032 Receives EMA Orphan Drug Designation in Duchenne Muscular Dystrophy
From AKAMPION
Via GlobeNewswire
News headline image
Ebenbuild Secures Euro 2.3 Million EIC Grant to Scale Digital Twin Platform for Respiratory Health
From AKAMPION
Via GlobeNewswire
News headline image
Thermosome Reports Encouraging Clinical Data of THE001 in Advanced Soft Tissue Sarcomas
From AKAMPION
Via GlobeNewswire
News headline image
Captain T Cell Joins Bayer Co.Lab Berlin to Accelerate Autologous and Allogeneic TCR-T Cell Therapy Programs for Cancer Patients
From AKAMPION
Via GlobeNewswire
News headline image
tiakis Biotech AG Announces Appointment of ex-Actelion Executive Christoph Schmidt as New Supervisory Board Member
From AKAMPION
Via GlobeNewswire
News headline image
Thermosome Receives U.S. Orphan Drug Designation for Lead Compound THE001, Expands Patent Estate
From AKAMPION
Via GlobeNewswire
News headline image
Dr. Stephan Rietiker elected as new Chairman of the Board of MetrioPharm AG
From AKAMPION
Via GlobeNewswire
News headline image
1STBIO and LigaChemBio Announce Strategic R&D and Licensing Option Agreement
From AKAMPION
Via GlobeNewswire
News headline image
Four new members elected to the Board of Directors of MetrioPharm AG
From AKAMPION
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.